Swiss biotech company, Engimmune Therapeutics completes its seed financing round raising CHF 15.5 million, co-led by Pureos Bioventures and Novo Holdings with incubation from BaseLaunch. Engimmune Therapeutics is a platform company using cutting-edge technologies
Tags :Lena Götzinger
GlycoEra has successfully completed a CHF 45 million Series A financing round, co-led by 5AM Ventures, Roche Venture Fund and Sofinnova Partners. LimmaTech Biologics, from which GlycoEra was spun-out, also participated in this round. GlycoEra’s
Ringier Axel Springer Schweiz, the media production company, is expanding its Services division and has acquired Gryps Offertenportal, a company specialised in procuring products and services for SMEs, from its founders and further shareholders. The
Illumiti Group, the SAP systems integration and management consultancies in North America, was acquired by Syntax Systems, a multi-cloud and multi-ERP managed cloud provider for mission-critical applications and a portfolio company of Novacap, a Montreal-based
The Walder Wyss team was led by Hubertus Hillerström (Partner, Corporate/M&A - pictured) and Anna Baldenbach von Bröchen (Senior Associate, Corporate/M&A)
